ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced that the Miami Neuroscience Center at Larkin Community Hospital has fully transitioned its ...

Around five million patients worldwide each year could benefit from radiosurgery for brain tumours and neurological disorders, yet fewer than 10% currently receive such treatment, according to John R.

SAN CARLOS, Calif.--(BUSINESS WIRE)--ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced that Haaglanden Medical Center (HMC) will become the first ...

Stereotactic radiosurgery (SRS) and stereotactic ablative body radiotherapy (SABR) have revolutionized precision oncology by delivering high‐dose, conformal radiation with submillimeter accuracy.

The machine, ZAP-X, enables Jersey Shore University doctors to more accurately treat the brain. The machine is one of only a few in the world. Jersey Shore medical doctor travels the world to share ...

NEPTUNE -- A Monmouth County hospital is home to a groundbreaking technology that is enabling new, more comfortable and precise forms of neurosurgery. Dr. Timothy Chen, a radiation oncologist and ...

Sponsored by ZAP Surgical Systems, Inc. In this webinar, get an inside look at European Radiosurgery Center Munich – a high-volume ZAP-X centre – with insights into its vault-free treatment suite, ...

Craniopharyngiomas account for 2–5% of all primary brain tumors and 5–10% of pediatric brain tumors. Despite their benign histology, their location near the hypothalamus, pituitary gland, and optic ...

Positron Emission Tomography–Guided Brentuximab Vedotin, Etoposide, Cyclophosphamide, Doxorubicin, Dacarbazine, and Dexamethasone in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma: A ...

A study at two US medical centers found that patients with brain metastases from gastrointestinal (GI) cancers had significantly worse overall survival and intracranial progression-free survival (PFS) ...

Deep Learning Model for Natural Language to Assess Effectiveness of Patients With Non–Muscle Invasive Bladder Cancer Receiving Intravesical Bacillus Calmette-Guérin Therapy Accurate identification of ...